Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer

Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs) Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers

Verwandte Artikel